Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 335.00
+10.00 (3.08%)
Oct 14, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €2.81 billion as of October 14, 2026. It is the 5,008th most valuable company in the world and the 83rd biggest in France. Its market cap has increased by 6.57% in one year.
Market Cap
2.81B
Enterprise Value
3.00B
Revenue
1.49B
Global Rank
Country Rank
#83 France
PE Ratio
18.03
ChartMarket Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 2.81B, an increase of 1,190.85%. That is a compound annual growth rate of 8.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 2.81B | -6.25% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 85.78B |
| EssilorLuxottica Société anonyme | 67.45B |
| Sartorius Stedim Biotech | 20.70B |
| Eurofins Scientific SE | 13.48B |
| ABIVAX Société Anonyme | 6.82B |
| emeis Société anonyme | 1.59B |
| Clariane SE | 1.18B |
| Ramsay Générale de Santé | 1.09B |